Vial Guide

Thymosin Beta-4 5 mg vial

How much bacteriostatic water to add to a 5 mg vial of Thymosin Beta-4, the syringe units for each common dose, and how many doses the vial holds.

Water
1 mL
Strength
5 mg/mL
Common dose
2.5 mg
Draw
50 units0.50 mL
Doses per vial
2

The short answer

Mixed with 1 mL of bacteriostatic water, a 5 mg vial of Thymosin Beta-4 holds 5 mg/mL. A 2.5 mg dose is then 50 units (0.50 mL) on a U-100 insulin syringe, and the vial holds about 2 doses of that size. Taken 2× per week, it lasts about 7 days.

Human studies. Tested in people as IV infusions, eye drops and wound gels, but never approved. The eye drops missed their main goals in two Phase 3 dry-eye trials (about 1,300 people) and in a European neurotrophic keratitis trial (June 2025); a second keratitis trial, SEER-2, finished in 2026, with top-line results expected around mid-November 2026. In China, an IV recombinant form is in Phase 2 trials for heart attack.
Thymosin Beta-4 page

How much water

The water only sets the strength; the dose and the number of doses in the vial stay the same. Draws are on a U-100 insulin syringe, where 1 unit is 0.01 mL.

Water addedStrengthPer syringe unitDraw for 2.5 mg
1 mL5 mg/mL50 mcg50 units (0.50 mL)
2 mL2.5 mg/mL25 mcg100 units (1.00 mL)
3 mL1.667 mg/mL16.7 mcg1.50 mL

Dose chart

Syringe units for each common dose at each water volume. Select a cell to open it in the calculator.

DoseWater added
1 mL2 mL3 mL
2 mg
2.5 mg

Draws over 100 units show in mL. Faded values are under 2 units, which is hard to measure. Check that your vial holds the larger volumes.

Where the doses come from

  • Trial IV infusion of 42–1,260 mg once daily for 14 days in healthy volunteers, a safety test only.
  • Trial Eye drops: 0.1% solution (RGN-259) 5× daily for 28 days in neurotrophic keratitis; 2–6× daily for 2–4 weeks in dry-eye trials.
  • Community No protocol specific to the full protein. Guides often treat it as the same thing as TB-500 and use that schedule: 2–2.5 mg under the skin twice weekly for 4–6 weeks, then about 2 mg weekly.

Doses are what labels, trials or community reports reference, not recommendations. Thymosin Beta-4’s page has the cycle, side effects, cautions and sources.

Mixing and storage

  1. PrepareLet a refrigerated vial come to room temperature, and wipe both stoppers with an alcohol swab.
  2. Add 1 mLDraw 1 mL of bacteriostatic water and let it run slowly down the inside wall of the vial.
  3. Swirl, don’t shakeSwirl gently until the powder dissolves and the liquid is clear.
  4. Label itWrite the date and the strength, 5 mg/mL, on the vial.

Storage: Powder: −20 °C long-term. Mixed: 2–8 °C, use within about 4 weeks.

The reconstitution guide covers each step, and the units page explains syringe markings.

Questions

How much water do I add to a 5 mg vial of thymosin beta-4?

There’s no single right amount: the water only sets the strength. With 1 mL of bacteriostatic water, a 5 mg vial holds 5 mg/mL. With 2 mL it’s 2.5 mg/mL; with 3 mL it’s 1.667 mg/mL. Less liquid makes each dose a smaller draw; more makes small doses easier to measure.

How many units is 2.5 mg of thymosin beta-4?

With 1 mL in a 5 mg vial, 2.5 mg is 50 units (0.50 mL) on a U-100 insulin syringe. With 2 mL, 100 units (1.00 mL); with 3 mL, 1.50 mL.

How many doses are in a 5 mg vial of thymosin beta-4?

About 2 doses of 2.5 mg, or 2 of 2 mg. Taken 2× per week at 2.5 mg, it lasts about 7 days.

How long does a mixed vial of thymosin beta-4 keep?

Powder: −20 °C long-term. Mixed: 2–8 °C, use within about 4 weeks.

Other vial sizes

Sources

  • Ruff et al., IV thymosin beta-4 in healthy volunteers, Phase 1 (Ann N Y Acad Sci 2010) PMID 20536472
  • Sosne et al., RGN-259 eye drops in neurotrophic keratopathy, SEER-1 (Int J Mol Sci 2022) PMID 36613994
  • ARISE-3 dry-eye trial, posted registry results (NCT03937882)
  • RegeneRx letter to stockholders on the SEER-2 trial (September 1, 2026)
  • FDA briefing document: TB-500-related bulk drug substances (July 2026)

The math on this page uses the doses and storage on Thymosin Beta-4’s page.